Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 3/2020

01-03-2020 | Prostate Cancer | Correction

Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

Authors: Johanna Maffey-Steffan, Lorenza Scarpa, Anna Svirydenka, Bernhard Nilica, Christian Mair, Sabine Buxbaum, Jasmin Bektic, Elisabeth von Guggenberg, Christian Uprimny, Wolfgang Horninger, Irene Virgolini

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2020

Login to get access

Excerpt

Correction to: European Journal of Nuclear Medicine and Molecular Imaging …
Metadata
Title
Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
Authors
Johanna Maffey-Steffan
Lorenza Scarpa
Anna Svirydenka
Bernhard Nilica
Christian Mair
Sabine Buxbaum
Jasmin Bektic
Elisabeth von Guggenberg
Christian Uprimny
Wolfgang Horninger
Irene Virgolini
Publication date
01-03-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2020
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04660-6

Other articles of this Issue 3/2020

European Journal of Nuclear Medicine and Molecular Imaging 3/2020 Go to the issue

Original Article

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

Book Review

ATLAS OF PET-CT, A Quick Guide to Image Interpretation

Short Communication

New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide

Editorial

18F-FDG PET/CT in patients with post-transplant lymphoproliferative disorders: so far so good

Short Communication

Planar scan vs. SPECT/low-dose CT for estimating split renal function by 99mTc-DMSA scintigraphy in children

Original Article

Clinicopathologic risk factors of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective cohort study